The objective is to investigate the biochemical and molecular mechanisms that regulate expression of specific differentiated functions in a model system of dispersed cells in culture. Studies will focus on: 1. Analyis of the acute actions of a regulatory peptide: thyrotropin-releasing hormone (TRH) as a prototype. Experiments will use clonal strains of pituitary cells and will examine the nature of the biochemical linkage between the TRH receptor and polyphosphatidylinositol hydrolysis, the mechanisms used by the cell for mobilization of intracellulr Ca2+, characterization of membrane cation channels, and the roles of protein kinase C and protein phosphorylation in acute actions of TRH on hormone (prolactin (PRL) and growth hormone (GH)) secretion. 2. Actions of tumor-promoting phorbol esters on differentiated functions. Phorbol esters will be localized in cells by a new immunohistochemical approach, and the mechanisms by which phorbol esters modulate plasma membrane receptors and regulate acute protein secretion (PRL and GH) will be investigated. 3. Regulation of specific protein synthesis. Using a highly differentiated cell culture system in which the biosynthesis of PRL and GH is controlled by hormones, Ca2+, and tumor promoters, I shall investigate the biochemical and molecular mechanisms by which phorbol esters and TRH regulate the biosynthesis of PRL and GH, and the role of Ca2+ in the regulatory pathway. The results of these studies will contribute new knowledge on the details of regulation of 2 important protein hormones; this fundamental knowledge can be expected to contribute to the better understanding of certain disorders of growth (including cancer) and reproductive function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK011011-23
Application #
3224730
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1975-09-01
Project End
1991-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
23
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Schools of Public Health
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Chen, F; Selinger, Z; Marks, P et al. (2001) Production and characterization of an antiserum which recognizes the native receptor for thyrotropin-releasing hormone. Biochem Biophys Res Commun 285:742-50
Chen, X; Tang, S; Tashjian Jr, A H (2000) Novel action of pituitary adenylate cyclase-activating polypeptide. Stimulation of extracellular acidification in rat pituitary GH4C1 cells. Cell Signal 12:255-63
Chen, L; Hoeger, C; Rivier, J et al. (1999) Structural basis for the binding specificity of a SSTR1-selective analog of somatostatin. Biochem Biophys Res Commun 258:689-94
Chen, L; Tashjian Jr, A H (1999) Identification of distinct signalling pathways for somatostatin receptors SSTR1 and SSTR2 as revealed by microphysiometry. Cell Signal 11:499-505
Petrou, C; Tashjian Jr, A H (1998) The thyrotropin-releasing hormone-receptor complex and G11alpha are both internalised into clathrin-coated vesicles. Cell Signal 10:553-9
Han, B; Tashjian Jr, A H (1998) User-friendly and versatile software for analysis of protein hydrophobicity. Biotechniques 25:256-9, 262-3
Chen, L; Fitzpatrick, V D; Vandlen, R L et al. (1997) Both overlapping and distinct signaling pathways for somatostatin receptor subtypes SSTR1 and SSTR2 in pituitary cells. J Biol Chem 272:18666-72
Petrou, C; Chen, L; Tashjian Jr, A H (1997) A receptor-G protein coupling-independent step in the internalization of the thyrotropin-releasing hormone receptor. J Biol Chem 272:2326-33
Xu, Y; Gilbert, B A; Rando, R R et al. (1996) Inhibition of capacitative Ca2+ entry into cells by farnesylcysteine analogs. Mol Pharmacol 50:1495-501
Han, B; Tashjian Jr, A H (1995) Identification of Asn289 as a ligand binding site in the rat thyrotropin-releasing hormone (THR) receptor as determined by complementary modifications in the ligand and receptor: a new model for THR binding. Biochemistry 34:13412-22

Showing the most recent 10 out of 48 publications